Altaris Capital Partners announced its majority investment in Chemical Computing Group (CCG) on June 8, 2017.
Altaris is an investment firm which focuses on the healthcare industry.
CCG, headquartered in Montreal, Canada, is a provider of molecular design software for pharmaceutical, chemical and material industries.
Adds to Altaris’s $2.4 billion portfolio of equity capital.
CCG’s software platform, the Molecular Operating Environment (MOE), streamlines drug discovery and chemical engineering processes by allowing researchers to visualize and predict molecular properties and interactions.
Financial advisor to Chemical Computing Group.